QMB provides an AI‑native regulatory intelligence platform called QualiVerse® that automates and accelerates New Product Development and FDA submissions for MedTech companies. By combining generative AI with expert oversight, the solution generates submission‑ready documentation, flags compliance risks, and aligns with global standards such as FDA, EU MDR, and ISO 13485, helping manufacturers reduce time‑to‑market, improve approval rates, and turn regulatory compliance into a strategic advantage.
No recent news for this company.